TT HealthWatch

Program notes:
0:35 Continuous glucose monitoring in Type 2 diabetes not using insulin
1:40 Decreased HbA1c
2:35 Already shown to be beneficial in those using insulin
3:30 Cancer vaccines
4:30 Disease-free survival endpoint
5:32 If T-cell population increased
6:30 Pregnancy outcomes in women who donate kidneys
7:30 Matched 4-to-1 with nonkidney donors
8:30 Timing of kidney donation
9:15 AI collaboration for managing epilepsy
10:15 Links EEGs to AI and smartphone app
11:15 Patients requested continuation
12:45 End

Program notes:
0:40 Clinician use of AI clinically
1:40 703,000 active monthly users
2:40 How helpful is this?
3:40 More up to date
3:50 Prognostic model to estimate fetal compromise
4:50 Data from singleton births
5:50 Fit4labour model
6:50 Could be used 8 hours before a problem
7:11 Drug coated balloons or stent
8:11 Indications are symptoms or high risk
8:40 US donor heart allocation
9:40 Best interests of their patient
10:40 Similar or significantly higher area under the curve
11:40 Can identify a higher risk group
12:54 End

Program notes:
0:36 HPV vaccines and pregnancy outcomes
1:36 600,000+ births
2:36 What is the mechanism?
3:30 Adult ADHD
4:30 May see underperformance
5:30 Almost always methylphenidate or amphetamine
6:30 Public health significance
7:01 Hospital closures in the U.S.
8:01 Safety net, non-teaching hospitals closed more
9:03 Advance care planning in black and white older adults
10:04 Racially concordant or discordant facilitator
11:08 Self-guided planning
12:10 Not doing a good job offering ACP
13:59 End

Program notes:
0:40 Lean metabolic associated liver disease
1:40 Biopsy confirmed MASLD
2:40 Elastography for diagnosis
3:41 Liver transplant often needed
4:04 HT and thromboembolic disease
5:04 VTE, ischemic stroke and MI
6:04 Oral estrogen increased risk
7:07 LIquid cancer biopsy impact
8:07 Not had cancer compared to routine screening
9:07 Not seeing a positive impact
10:05 Inter-interval breast cancers
10:31 How to manage early septic shock
11:31 Main outcome alive and out of the hospital at day 90
12:30 Both are equally effective
13:20 End

Program notes:
0:33 Statins for older people without CVD
1:34 Followed for six years
2:34 Aged to 70 without CVD
3:00 Improving primary care for folks with chronic conditions
4:00 70,000 respondents
5:00 Long term relationship with a primary care provider
6:00 Continuity and coordination can be delivered at scale
7:09 Treating advanced breast cancer
8:10 Mutation in estrogen receptor
9:12 Targeting specific mutations
10:00 A new target for managing asthma and COPD
11:00 Healthy volunteers and patients with asthma
12:00 Typically treated with immunosuppression
13:05 End